Fabiana Gentilini

Fabiana Gentilini

UNVERIFIED PROFILE

Are you Fabiana Gentilini?   Register this Author

Register author
Fabiana Gentilini

Fabiana Gentilini

Publications by authors named "Fabiana Gentilini"

Are you Fabiana Gentilini?   Register this Author

18Publications

270Reads

19Profile Views

[Immunotherapy and cancer: towards 2020.]

Recenti Prog Med 2018 Dec;109(12):566-569

Bristol-Myers Squibb Italia.

View Article

Download full-text PDF

Source
http://www.recentiprogressi.it/articoli.php?archivio=yes&
Publisher Site
http://dx.doi.org/10.1701/3082.30740DOI Listing
December 2018

Bendamustine and dexamethasone are an effective salvage regimen for patients with advanced multiple myeloma in a Home Care Unit program.

Leuk Lymphoma 2016 07 23;57(7):1716-8. Epub 2015 Dec 23.

a Department of Cellular Biotechnologies and Hematology , "Sapienza" University , Via Benevento 6 , Rome 00153 , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1106531DOI Listing
July 2016

Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits.

Patient Prefer Adherence 2014 4;8:939-46. Epub 2014 Jul 4.

Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PPA.S38142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094627PMC
July 2014

Bortezomib a safe treatment for patients with multiple myeloma and cystic fibrosis.

Mediterr J Hematol Infect Dis 2012 7;4(1):e2012035. Epub 2012 May 7.

Hematology, "Sapienza" University of Rome. Via Benevento 6, 00161 Rome (Italy).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2012.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375716PMC
October 2012

Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.

Leuk Lymphoma 2009 Nov;50(11):1803-8

Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903254383DOI Listing
November 2009

Ocular side effects in chronic myeloid leukemia patients treated with imatinib.

Leuk Res 2008 Jul 3;32(7):1022-5. Epub 2007 Dec 3.

Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.10.016DOI Listing
July 2008

Cocaine abuse may influence the response to imatinib in CML patients.

Haematologica 2007 Mar;92(3):e41-2

Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.10976DOI Listing
March 2007

Myelodysplastic syndromes in patients under 50 years old: a single institution experience.

Leuk Res 2005 Jul 24;29(7):749-54. Epub 2005 Feb 24.

Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.01.003DOI Listing
July 2005

Paroxysmal cold haemoglobinuria as a tardive complication of idiopathic myelofibrosis.

Eur J Haematol 2004 Oct;73(4):304-6

Department of Cellular Biotechnology and Hematology, University La Sapienza, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2004.00301.xDOI Listing
October 2004